Myechia Minter-Jordan, M.D.

Dr. Myechia Minter-Jordan graduated from Brown University School of Medicine and the Johns Hopkins University Carey School of Business. She also received honorary doctorates from Northeastern University and Newbury College.

She is President and CEO for the DentaQuest Partnership for Oral Health Advancement and Catalyst Institute. In this role, she oversees the DentaQuest Partnership for Oral Health Advancement and Impact Group, leading research and grantmaking activities focused on improving oral health, integrating oral health and overall health through medical/dental collaborations, moving toward a value-based payment model, and guiding a growing research and data portfolio.

Myechia joined DentaQuest in 2019 after twelve years at the Roxbury, Mass.-based Dimock Center. Considered a national model for comprehensive health and human services, Dimock focuses on the integration of clinical and behavioral health and is the second largest health center in the Boston area. As CEO, Myechia formed partnerships with world-class institutions, including Harvard Medical School, Beth Israel Deaconess Medical Center, and Partners HealthCare to advance person-centered care.

Before her position as CEO, Myechia served as Chief Medical Officer at Dimock and successfully led transformative efforts including the switch to an electronic medical record system, establishing an Institutional Review Board, and earning a $4.9 million federal grant to become a designated primary medical home. Prior to Dimock, Myechia worked for Johns Hopkins Medicine as an attending physician and instructor of medicine.

Myechia serves on several boards and committees that include the Yawkey Foundation, The Boston Foundation, Harvard School of Dental Medicine, Harvard Pilgrim Health Care and the Isabella Stewart Gardner Museum.

In the past, she has served on several boards and committees that include appointed positions within the Commonwealth of Massachusetts and the City of Boston including MA Health Planning Council Advisory Committee, the Boston Public Health Commission, and RIZE Massachusetts where she focused on combating the opioid epidemic.